Skip to content
DataLookout
Menu

NCT07911618

Data Collection For Patients With Sickle Cell Disease

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

safety and adverse events (AEs)
Timeframe: Through study completion; an average of 1 year

Arms and interventions

Other: data collection

Sites

1 site in 1 country

  • UT MD Anderson Cancer CenterHouston, Texas, United States